Orson Moe is a Nephrology physician affiliated with Southwestern Medical Center. OpenAlex indexes 13 publications with 408 citations (h-index 2).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5323 Harry Hines Blvd
Dallas, TX 753907208
Telephone
214-645-8600Registry record last updated 3 Apr 2008.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20253 payments
- Biosense Webster, Inc.Program year20251 payment
- IDORSIA PHARMACEUTICALS US INCProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%Metabolic Alkalinizer100%Potassium Citrate Er100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
13 NIH research awards on record, funded 1995–2023 per NIH RePORTER. The latest:
- Origin of Excess Acid in Uric Acid Urolithiasis
Ut Southwestern Medical Center
FY2023$449,722R01DK115703
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hydroxycitrate is a Unique Inhibitor of Pathologically-Relevant Brushite Crystallization
ACS Applied Materials & Interfaces
2026 - High-Phosphate-Induced Hypertension: The Pathogenic Role of Fibroblast Growth Factor 23 (FGF23) Signaling in Sympathetic Nervous System Activation
International Journal of Molecular Sciences
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Claus Roehrborn, MD
Southwestern Medical Center
Trish Perl, MD
Southwestern Medical Center
Lisa Vanwagner, MD
Southwestern Medical Center
Jose Joglar, MD
Southwestern Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”